Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to demonstrate non-inferiority of Dotarem®-enhanced MRI as compared to Gadovist®/ Gadavist®-enhanced MRI in the diagnosis of brain tumors in terms of overall lesion visualization and characterization (off-site assessment).

270 patients will be randomized between 2 arms defining the sequence of administration of the contrast agents at the dose of 0.1mmol/kg, with a minimum of 48 hours and a maximum of 14 days in between.

Each patient will, therefore, receive two MRI during his/her participation in the study.

The two arms consist in :

- Dotarem® in the first MRI, then Gadovist®/Gadavist® in the second MRI.

- Gadovist®/Gadavist® in the first MRI, then Dotarem® in the second MRI.

Contrast-enhanced MRIs will be performed on 1.5 or 3 Tesla systems.

MRI examinations will be evaluated centrally by blinded independent readers for the main evaluation criterion.


Clinical Trial Description

n/a


Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Diagnostic


Related Conditions & MeSH terms


NCT number NCT02034708
Study type Interventional
Source Guerbet
Contact
Status Completed
Phase Phase 4
Start date June 2014
Completion date September 2015

See also
  Status Clinical Trial Phase
Recruiting NCT05539677 - Biobank and Register of Patients With Agresive Tumors for Translational and Analytical Research
Recruiting NCT04066465 - Neurocognitive Function After Proton Therapy in Children and Adolescents
Completed NCT02392078 - Laser Ablation of Abnormal Neurological Tissue Using Robotic NeuroBlate System
Not yet recruiting NCT02272452 - Assistance in Neurosurgery (ExtempoRMN) N/A
Recruiting NCT06104488 - A Study of Avutometinib for People With Solid Tumor Cancers Phase 1
Completed NCT02338037 - Neuropharmacokinetics of Eribulin Mesylate in Treating Patients With Primary or Metastatic Brain Tumors Early Phase 1
Completed NCT05328739 - The Effect of Home Care Planned According to Orem in Patients With Primary Brain Tumor and Their Caregivers N/A
Terminated NCT00629395 - Computerized Cognitive Training for Childhood Cancer Survivors N/A
Completed NCT04919993 - CBT for Insomnia in Primary Brain Tumor Patients N/A
Completed NCT04075370 - Exploring Compensation to Maintain Cognitive Function in Adults Newly Diagnosed With Brain Cancer
Completed NCT01242566 - Temozolomide in Elderly Patients With KPS < 70 Phase 2
Not yet recruiting NCT06439420 - CBT-I in Primary Brain Tumor Patients: Phase IIc Randomized Feasibility Pilot Trial Phase 2
Recruiting NCT01535430 - Assessment of Eloquent Function in Brain Tumor Patients
Completed NCT00285324 - Diffusion Tensor MRI to Distinguish Brain Tumor Recurrence From Radiation Necrosis N/A
Recruiting NCT03684109 - Non-invasive Glioma Characterization Through Molecular Imaging N/A
Recruiting NCT05576103 - Longitudinal Prospective Study of Neurocognition & Neuroimaging in Primary BT Patients
Not yet recruiting NCT00265174 - Serum DNA Analysis: Potential Application for Diagnosis and Prognosis in Brain Cancer. N/A
Recruiting NCT05106296 - Chemo-immunotherapy Using Ibrutinib Plus Indoximod for Patients With Pediatric Brain Cancer Phase 1
Completed NCT04118426 - Cognitive Function After Radiation Therapy for Brain Tumours
Recruiting NCT02693405 - Executive and Socio-cognitive Functions in Survivors of Primary Brain Tumor: Impact on Patients' Quality of Life N/A